Factor VIII inhibiting antibody screening is a functional laboratory test that detects the presence and activity of inhibitory antibodies directed against factor VIII in blood plasma. These inhibitors neutralize the effectiveness of exogenous factor VIII therapy, leading to patient non-response to conventional treatment, which is one of the major therapeutic challenges in hemophilia A.